(MENAFN- PR Newswire)
DUBLIN, June 22, 2022 /PRNewswire/ -- The 'Virus Filtration Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027' report has been added to ResearchAndMarkets.com's offering.
The global virus filtration market reached a value of US$ 3.6 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 6.7 Billion by 2027, exhibiting at a CAGR of 11.2% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Virus filtration is an effective, non-destructive, and easy to use method of retaining both enveloped and non-enveloped virus particles on the surface or within the pores of a polymeric membrane. It finds extensive applications in continuous bioprocessing, which is gaining traction in monoclonal antibodies (MAbs) for providing small facility footprints.
As it does not impact the product quality, it is considered an ideal solution for manufacturing biological products, such as vaccines, somatic cells, gene therapy, and recombinant therapeutic proteins, and enhancing their safety. It is also used to remove blood-borne pathogens from plasma-derived products.The urgent need for potential therapies and vaccines to treat coronavirus disease (COVID-19) patients under critical conditions is promoting the application of virus filtration in the convalescent plasma for reducing inflammatory mediators. Moreover, advancements in bioprocessing technologies, including single-use equipment, perfusion reactors, and chromatography resins, are positively influencing the adoption of virus filtration in the manufacturing of various biotherapeutic products.
The increasing demand for these products can be associated with the significant rise in the prevalence of chronic diseases worldwide.
Additionally, regulatory agencies of numerous countries have mandated virus control at various stages of the drug manufacturing process to ensure the virological safety of biological therapeutics, which is also contributing to the market growth. Apart from this, the introduction of an advanced asymmetric membrane structure that provides no impact on virus retention through pressure variations, high loads, or process interruptions is anticipated to stimulate the market growth.
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Medical Co. Ltd., Charles River Laboratories, Inc., Clean Cells, Danaher Corporation, Merck KGaA, Sartorius AG and Thermo Fisher Scientific Inc. Key Questions Answered in This Report:
- How has the global virus filtration market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global virus filtration market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global virus filtration market and who are the key players?
- What is the degree of competition in the industry?
Key Topics Covered: 1 Preface 2 Scope and Methodology
3 Executive Summary 4 Introduction 4.1 Overview4.2 Key Industry Trends 5 Global Virus Filtration Market 5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Forecast 6 Market Breakup by Product 6.1 Consumables6.1.1 Market Trends6.1.2 Major Types6.1.2.1 Kits and Reagents6.1.2.2 Others6.1.3 Market Forecast6.2 Instruments6.2.1 Market Trends6.2.2 Major Types6.2.2.1 Filtration Systems6.2.2.2 Chromatography Systems6.2.3 Market Forecast6.3 Services6.3.1 Market Trends6.3.2 Market Forecast 7 Market Breakup by Application 7.1 Biologicals7.1.1 Market Trends7.1.2 Major Types7.1.2.1 Vaccines and Therapeutics7.1.2.2 Blood and Blood Products7.1.2.3 Cellular and Gene Therapy Products7.1.2.4 Others7.1.3 Market Forecast7.2 Medical Devices7.2.1 Market Trends7.2.2 Market Forecast7.3 Water Purification7.3.1 Market Trends7.3.2 Market Forecast7.4 Air Purification7.4.1 Market Trends7.4.2 Market Forecast7.5 Others7.5.1 Market Trends7.5.2 Market Forecast 8 Market Breakup by End Use 8.1 Biopharmaceuticals and Biotechnology Companies8.1.1 Market Trends8.1.2 Market Forecast8.2 Contract Research Organizations8.2.1 Market Trends8.2.2 Market Forecast8.3 Academic Institutes and Research Laboratories8.3.1 Market Trends8.3.2 Market Forecast8.4 Others8.4.1 Market Trends8.4.2 Market Forecast 9 Market Breakup by Region 10 SWOT Analysis 11 Value Chain Analysis 12 Porters Five Forces Analysis
13 Price Analysis 14 Competitive Landscape 14.1 Market Structure14.2 Key Players14.3 Profiles of Key Players14.3.1 Asahi Kasei Medical Co. Ltd.14.3.1.1 Company Overview14.3.1.2 Product Portfolio14.3.2 Charles River Laboratories Inc.14.3.2.1 Company Overview14.3.2.2 Product Portfolio14.3.2.3 Financials14.3.2.4 SWOT Analysis14.3.3 Clean Cells14.3.3.1 Company Overview14.3.3.2 Product Portfolio14.3.3.3 Financials14.3.4 Danaher Corporation14.3.4.1 Company Overview14.3.4.2 Product Portfolio14.3.4.3 Financials14.3.4.4 SWOT Analysis14.3.5 Merck KGaA14.3.5.1 Company Overview14.3.5.2 Product Portfolio14.3.6 Sartorius AG14.3.6.1 Company Overview14.3.6.2 Product Portfolio14.3.6.3 Financials14.3.6.4 SWOT Analysis14.3.7 Thermo Fisher Scientific Inc.14.3.7.1 Company Overview14.3.7.2 Product Portfolio14.3.7.3 Financials14.3.7.4 SWOT Analysis
For more information about this report visit
Media Contact:
Research and MarketsLaura Wood, Senior Manager[email protected]
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
MENAFN22062022003732001241ID1104416972
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.